Prostate Cancer - Results from #20500

Does statin or ASA affect survival when prostate cancer is treated with external beam radiation therapy? - Abstract May 24, 2014

Prospective study on the relationship between clinical efficacy of secondary hormone therapy with flutamide and neuroendocrine differentiation in patients with relapsed prostate cancer after first line hormone therapy - Abstract May 24, 2014

Angiosarcoma of the prostate: A more frequent finding in the future owing to radiotherapy? A literature review with treatment implications based on a case report - Abstract May 24, 2014

Outcomes of men with an elevated PSA as their sole preoperative intermediate or high risk feature - Abstract May 23, 2014

When is prostate cancer really cancer? - Abstract May 23, 2014

Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer - Abstract May 23, 2014

Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer - Abstract May 23, 2014

Weight gain on androgen deprivation therapy: Which patients are at highest risk? - Abstract May 22, 2014

Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels - Abstract May 22, 2014

Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: Non-isocentric CyberKnife versus isocentric RapidArc - Abstract May 22, 2014

Exploring the role of the partner in couples' sexual recovery after surgery for prostate cancer - Abstract May 22, 2014

Skeletal-related events and mortality among older men with advanced prostate cancer - Abstract May 22, 2014

Screening and detection advances in magnetic resonance image-guided prostate biopsy - Abstract May 21, 2014

Management of an increasing prostate-specific antigen level after negative prostate biopsy - Abstract May 21, 2014

Prolaris® test predicts mortality risk in prostate cancer biopsy study May 21, 2014

Treatment with PROVENGE ® (sipuleucel-T) induces antigen spread associated with overall survival benefits in advanced prostate cancer data from ProACT, IMPACT and PROCEED to be presented at the 2014 American Urological Association (AUA) annual meeting May 21, 2014

Decision making and prostate cancer screening - Abstract May 20, 2014

Emerging PSA-based tests to improve screening - Abstract May 20, 2014

Beckman Coulter’s phi named in NCCN Guidelines as a recommended diagnostic test for early prostate cancer detection May 20, 2014

Metabolic syndrome disorders, diet may boost prostate cancer risk May 20, 2014

Page 1026 of 1435